Rimtaxime 500 mg

Description

Rimtaxime 500 mg is an ANVIS product. Its packaging identifies Cefotaxime USP in powder for injection form. This entry records the visible product specification and shows the original carton with the vial outside it.

Rimtaxime 500 mg product specification

• Product name: Rimtaxime 500 mg
• Ingredient: Cefotaxime USP
• Labelled strength: 500 mg per vial
• Dosage form: Powder for injection
• Presentation: Carton with an external vial shown
• Labelled routes: Intravenous (IV) and intramuscular (IM)
• Brand: ANVIS

First, match the full name, strength and formulation to the item supplied. For example, a different strength needs separate identification. Packaging details describe the presentation; they do not establish a dose or treatment duration. Therefore, consult the supplied leaflet and your healthcare professional before use.

General information about cefotaxime

Cefotaxime belongs to the cephalosporin group of antibiotics. Clinicians use it for selected bacterial infections. However, antibiotics do not treat viral illnesses such as colds or flu. The clinician must choose treatment based on the infection and the patient’s circumstances.

Rimtaxime 500 mg: important precautions

Before treatment, tell your clinician about allergies to cephalosporins or penicillins. Also discuss kidney disease, bowel problems, other medicines, pregnancy or breastfeeding. Follow the prescribed course and professional instructions for preparation and administration. Do not select a diluent or prepare an injection from this catalogue entry.

Seek urgent help for breathing difficulty, facial swelling or a severe skin reaction. In addition, contact your clinician for severe watery or bloody diarrhoea. The vial label states storage below 30°C; follow the supplied instructions for handling and any prepared solution.

Documentation and product enquiries

The MedlinePlus cefotaxime guide provides background on the ingredient, not the complete specification of this ANVIS product. Review the supplied leaflet for current local instructions. For further Rimtaxime 500 mg documentation, contact ANVIS with the product name and presentation. Alternatively, browse our injection catalogue.